The DOI matches its OpenAlex record; 15 of the 15 references it cites were found in a registry or an index.
Risk of malignancies in IgG4-related disease
Abstract
IgG4-related disease (IgG4-RD) is considered a systemic, chronic, and inflammatory disorder that is characterized by the enlargement of involved organs, elevated levels of IgG4, and abundant infiltration of plasmacytes with IgG4 and fibrosis in involved organs. It is necessary to differentiate IgG4-RD from malignant tumors. Recently we have looked at case reports of IgG4-RD with malignancy that was discovered at systemic screening. In this study, we analyzed the relationship between IgG4-RD and malignancies. The study subjects were 106 patients with IgG4-RD who had been referred to our hospital since April 1997. We analyzed the clinical characteristics of IgG4-RD patients who had cancer that was observed upon the initial diagnosis of IgG4-RD or that occurred during an average follow-up period of 3.1 years. Using data from national cancer registries that monitor cancer incidence in Japan, we evaluated the standardized incidence ratio (SIR) for malignancies in IgG4-RD. Malignancies were observed in 11 of the IgG4-RD patients (10.4%). The malignancies were all different and included lung cancer, colon cancer, and lymphoma. With the exception of the age at which the IgG4-RD diagnosis was made, there were no common features in patients with cancer and those without. The SIR for these malignancies in IgG4-RD was 383.0, which was higher than that for the general population. We should be cognizant of the possible existence of malignancies in patients with IgG4-RD at the time of diagnosis and during follow-up care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
High Serum IgG4 Concentrations in Patients with Sclerosing Pancreatitis
Hamano, H., Kawa, S., Horiuchi, A., Unno, H., Furuya, N., Akamatsu, T., Fukushima, M., Nikaido, T., Nakayama, K., Usuda, N., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441005 · Cited by 2,705
Travis, W. D., Castile, R., Vawter, G., Shwachman, H., Warwick, W., Burke, B. A., & Skinner, M. (1986) · American Journal of Clinical Pathology · doi:10.1093/ajcp/85.4.419 · Cited by 1,189
The Risk of Lymphoma Development in Autoimmune Diseases: A Meta-analysis
Zintzaras, E. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.20.2337 · Cited by 771
Matsuda, A., Matsuda, T., Shibata, A., Katanoda, K., Sobue, T., Nishimoto, H., & The Japan Cancer Surveillance Research Group (2014) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyu003 · Cited by 569
Ghazale, A., Chari, S. T., Smyrk, T. C., Levy, M. J., Topazian, M. D., Takahashi, N., Clain, J. E., Pearson, R. K., Pelaez-Luna, M., Petersen, B. T., et al. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01264.x · Cited by 551
IgG4‐related disease: Historical overview and pathology of hematological disorders
Sato, Y., Notohara, K., Kojima, M., Takata, K., Masaki, Y., & Yoshino, T. (2010) · Pathology International · doi:10.1111/j.1440-1827.2010.02524.x · Cited by 263
Teng, M. W. L., Ngiow, S. F., von Scheidt, B., McLaughlin, N., Sparwasser, T., & Smyth, M. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1681 · Cited by 192
The birthday of a new syndrome: IgG4-related diseases constitute a clinical entity
Takahashi, H., Yamamoto, M., Suzuki, C., Naishiro, Y., Shinomura, Y., & Imai, K. (2010) · Autoimmunity Reviews · doi:10.1016/j.autrev.2010.05.003 · Cited by 167
Self-citationMatsuda, T., Marugame, T., Kamo, K., Katanoda, K., Ajiki, W., & Sobue, T. (2009) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyp106 · Cited by 162
Incidence of cancer in a cohort of patients with primary Sjogren's syndrome
Lazarus, M. N., Robinson, D. S., Mak, V., et al. (2006) · Lara D. Veeken · doi:10.1093/rheumatology/kei281 · Cited by 157
Cited by
Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011
Umehara, H., Okazaki, K., Masaki, Y., Kawano, M., Yamamoto, M., Saeki, T., Matsui, S., Yoshino, T., Nakamura, S., Kawa, S., et al. (2012) · Modern Rheumatology · doi:10.1007/s10165-011-0571-z · Cited by 2,028
Self-citationKamisawa, T., Zen, Y., Pillai, S., & Stone, J. H. (2015) · The Lancet · doi:10.1016/s0140-6736(14)60720-0 · Cited by 1,212
Huggett, M. T., Culver, E. L., Kumar, M., Hurst, J. M., Rodriguez-Justo, M., Chapman, M. H., Johnson, G. J., Pereira, S. P., Chapman, R. W., Webster, G. J. M., et al. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.223 · Cited by 266
Risk of Cancer in Patients With Autoimmune Pancreatitis
Shiokawa, M., Kodama, Y., Yoshimura, K., Kawanami, C., Mimura, J., Yamashita, Y., Asada, M., Kikuyama, M., Okabe, Y., Inokuma, T., et al. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.465 · Cited by 254
European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations
Löhr, J., Beuers, U., Vujasinovic, M., Alvaro, D., Frøkjær, J. B., Buttgereit, F., Capurso, G., Culver, E. L., de‐Madaria, E., Della‐Torre, E., et al. (2020) · United European Gastroenterology Journal · doi:10.1177/2050640620934911 · Cited by 252
Metadata
- Authors
- Yamamoto, M., Takahashi, H., Tabeya, T., Suzuki, C., Naishiro, Y., Ishigami, K., Yajima, H., Shimizu, Y., Obara, M., Yamamoto, H., Himi, T., Imai, K., & Shinomura, Y.
- Venue
- Modern Rheumatology
- Publisher
- Oxford University Press
- Published
- 2011-09-06
- Volume
- 22
- Issue
- 3
- Pages
- 414-418
- ISSN
- 1439-7595 (ISSN-L)
- OpenAlex
- W2073601476
- Cited by
- 253
- References
- 15
- FWCI
- 12.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Risk of malignancies in IgG4-related disease. https://app.cochat.ai/papers/10.1007/s10165-011-0520-x
- The paper
- Yamamoto, M., Takahashi, H., Tabeya, T., Suzuki, C., Naishiro, Y., Ishigami, K., Yajima, H., Shimizu, Y., Obara, M., Yamamoto, H., Himi, T., Imai, K., & Shinomura, Y. (2011). Risk of malignancies in IgG4-related disease. Modern Rheumatology. https://doi.org/10.1007/s10165-011-0520-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.